20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Dexlansoprazole: The Next Generation of Proton Pump Inhibitors from NINGBO INNO PHARMCHEM

NINGBO INNO PHARMCHEM CO.,LTD. is pleased to feature Dexlansoprazole, the R-enantiomer of Lansoprazole, a cutting-edge pharmaceutical intermediate that is transforming the treatment of acid-related gastrointestinal conditions. This advanced proton pump inhibitor (PPI) offers distinct advantages over traditional racemic mixtures, primarily due to its unique pharmacokinetic profile and innovative drug release technology.

The development of Dexlansoprazole represents a significant leap forward in gastrointestinal pharmacology. Unlike racemic Lansoprazole, which is a 1:1 mixture of R and S enantiomers, Dexlansoprazole isolates the active R-enantiomer. This precise formulation leads to a slower clearance and a longer terminal half-life, ensuring a more consistent and prolonged reduction in gastric acid secretion. This makes it a highly effective treatment for conditions such as symptomatic non-erosive GERD, healing of erosive esophagitis, and maintaining the healing of such conditions.

At NINGBO INNO PHARMCHEM CO.,LTD., we understand the critical need for high-purity pharmaceutical intermediates like Dexlansoprazole (CAS 138530-94-6) to support drug development and manufacturing. Our commitment is to provide reliable access to this compound, enabling pharmaceutical companies to produce next-generation therapies. The focus on R-lansoprazole chemical properties and synthesis pathways underscores the scientific precision involved in creating such advanced medications.

The advantage of Dexlansoprazole also lies in its dual-release formulation. This technology allows for two distinct release phases of the medication, typically one within 1-2 hours and another 4-5 hours after administration. This staggered release pattern optimizes the drug's efficacy by providing sustained acid control throughout the day. For patients, this can mean more comprehensive relief from symptoms and a better overall treatment experience. When you choose to purchase R-(+)-Lansoprazole from NINGBO INNO PHARMCHEM CO.,LTD., you are investing in quality and reliability for your pharmaceutical needs.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Science Behind R-(+)-Lansoprazole: Enhancing Gastric Acid Control

Next: Sourcing R-(+)-Lansoprazole (CAS 138530-94-6): A Guide for Pharmaceutical Researchers

All Rights Reserved